Show simple item record

dc.contributor.authorCómitre-Mariano, Blanca
dc.contributor.authorMartínez-García, Magdalena
dc.contributor.authorGarcía-Gálvez, Bárbara
dc.contributor.authorPaternina-Die, María
dc.contributor.authorDesco, Manuel 
dc.contributor.authorCarmona, Susanna
dc.contributor.authorGómez-Gaviro, María Victoria
dc.date.accessioned2023-03-17T10:46:30Z
dc.date.available2023-03-17T10:46:30Z
dc.date.issued2022-01-21
dc.identifier.citationiScience. 2021 Dec 29;25(1):103664es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/15664
dc.description.abstractThere is a bidirectional transplacental cell trafficking between mother and fetus during pregnancy in placental mammals. The presence and persistence of fetal cells in maternal tissues are known as fetal microchimerism (FMc). FMc has high multilineage potential with a great ability to differentiate and functionally integrate into maternal tissue. FMc has been found in various maternal tissues in animal models and humans. Its permanence in the maternal body up to decades after delivery suggests it might play an essential role in maternal pathophysiology. Studying the presence, localization, and characteristics of FMc in maternal tissues is key to understanding its impact on the woman's body. Here we comprehensively review the existence of FMc in different species and organs and tissues, aiming to better characterize their possible role in human health and disease. We also highlight several methodological considerations that would optimize the detection, quantification, and functional determination of FMc.es_ES
dc.description.sponsorshipThis work was supported by Ministerio de Ciencia e Innovación project RTI2018-093952-B-100 and by Instituto de Salud Carlos III projects CP16/00096, PI18/00462 and PI17/00064, and co-funded by European Regional Development Fund (ERDF), A way to make Europe. MMG was funded by Ministerio de Ciencia e Innovación, Instituto de Salud Carlos III, Predoctorales de Formación en Investigación en Salud (PFIS) (contract FI18/00255) and a predoctoral Fulbright grant. BC was supported by Consejería de Educación e Investigación, Comunidad de Madrid, co-funded by European Social Fund ‘‘Investing in your future’’ (PEJD-2019-PRE/BMD-16977). SC was funded by a Miguel Servet Type I research contract (CP16/00096). MM-G and SC were co-funded by European Social Fund Investing in your future. The project leading to these results has received funding from la Caixa Foundation under the project code LCF/PR/HR19/ 52160001, from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme (grant agreement No 883069), and from the Centro Nacional de Investigaciones Cardiovasculares (CNIC). The CNIC is supported by Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia e Innovación and the Pro CNIC Foundation, and is a Severo Ochoa Center of Excellence (SEV2015-050). We thank Vicente Llorente Úbeda for reading the manuscript.es_ES
dc.language.isoenges_ES
dc.publisherCell Press es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleFeto-maternal microchimerism: Memories from pregnancy.es_ES
dc.typereviewes_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.identifier.pubmedID35072002es_ES
dc.format.volume25es_ES
dc.format.number1es_ES
dc.format.page103664es_ES
dc.identifier.doi10.1016/j.isci.2021.103664es_ES
dc.contributor.funderMinisterio de Ciencia e Innovación (España) es_ES
dc.contributor.funderInstituto de Salud Carlos III es_ES
dc.contributor.funderUnión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) es_ES
dc.contributor.funderUS-UK Fulbright Commission es_ES
dc.contributor.funderComunidad de Madrid (España) es_ES
dc.contributor.funderFundación La Caixa es_ES
dc.contributor.funderUnión Europea. Comisión Europea. European Research Council (ERC) es_ES
dc.contributor.funderUnión Europea. Comisión Europea. Horizonte Europa es_ES
dc.contributor.funderFundación ProCNIC es_ES
dc.contributor.funderMinisterio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España) es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn2589-0042es_ES
dc.relation.publisherversion10.1016/j.isci.2021.103664es_ES
dc.identifier.journaliSciencees_ES
dc.repisalud.orgCNICCNIC::Unidades técnicas::Imagen Avanzadaes_ES
dc.repisalud.institucionCNICes_ES
dc.relation.projectIDinfo:eu-repo/grantAgreement/EC/H2020/883069es_ES
dc.rights.accessRightsopen accesses_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/RTI2018-093952-B-100es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/CP16/00096es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI18/00462es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PI17/00064es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/FI18/00255es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PEJD-2019-PRE/BMD-16977es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/e LCF/PR/HR19/52160001es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/SEV2015-050es_ES


Files in this item

Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
This item is licensed under a: Attribution-NonCommercial-NoDerivatives 4.0 Internacional